EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced the Trans‐Cleavage Activity of CRISPR‐Cas12a Using Metal‐Organic Frameworks as Stimulants for Efficient Electrochemical Sensing of Circulating Tumor DNA

Shuai Wu, Yincheng Liu, Tianyu Zeng, Tianci Zhou, Yanting Sun, Ying Deng, Juan Zhang iD, Genxi Li iD, Yongmei Yin iD

Advanced Science · 2025-06 · 12 (22)

DOI: 10.1002/advs.202417206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 04.04.2025. Verfasst von Shuai Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, 210029, P. R. China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Biosensing Techniques, CRISPR-Cas Systems, Electrochemical Techniques. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Collaborative Innovation Center for Tumor Individualization Program, Doctoral Program for Entrepreneurship and Innovation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Continued development of clustered regularly interspaced short palindromic repeats (CRISPR)‐powered biosensing system on the electrochemical interface is vital for accurate and timely diagnosis in clinical practice. Herein, an electrochemical biosensor based on manganese metal‐organic frameworks (MOFs)‐enhanced CRISPR (MME‐CRISPR) is proposed that enables the efficient detection of circulating tumor DNA (ctDNA). In this design, customized enzyme stimulants (Mn 2+ ) are co‐assembled with Cas12a/crRNA to form enzyme‐MOF composites, which can be released quickly under mild conditions. The MOFs‐induced proximity effect can continuously provide adequate Mn 2+ to sufficiently interact with Cas12a/crRNA during the release process, enhancing the trans‐cleavage activity of complex available for biosensor construction. The MOFs‐based enzyme biocomposites also afford efficient protection against various external stimulus. It is demonstrated that the developed biosensor can achieve ultrasensitive detection of epidermal growth factor receptor L858R mutation in ctDNA with a low detection limit of 0.28 f m without pre‐amplification. Furthermore, the engineered mismatch crRNA enables the biosensor based on MME‐CRISPR to detect single nucleotide variant with a high signal‐to‐noise ratio. More importantly, it has been successfully used to detect the targets in clinical practice, requiring low‐dose samples and a short time. This strategy is believed to shed new light on the applications of cancer diagnosis, treatment, and surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal-Organic FrameworksBiosensing TechniquesCRISPR-Cas SystemsElectrochemical TechniquesCirculating Tumor DNAEndodeoxyribonucleasesHumansLimit of DetectionBacterial ProteinsCRISPR-Associated Proteins

Stichwörter der Autor:innen

CRISPR‐based diagnosticsCas12a/crRNAcirculating tumor DNAelectrochemical biosensormetal‐organic framework

Substanzen

Metal-Organic FrameworksCirculating Tumor DNAEndodeoxyribonucleasesCas12a proteinBacterial ProteinsCRISPR-Associated Proteins

Autor:innen und Institutionen

  • Clinical Research Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, 210029, P. R. China.
  • Department of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, P. R. China.
  • Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, P. R. China.
  • State Key Laboratory of Analytical Chemistry for Life Science, School of Life Sciences, Nanjing University, Nanjing, 210023, P. R. China.
  • Center for Molecular Recognition and Biosensing, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China.

ORCID-Profile: Juan Zhang, Genxi Li, Yongmei Yin

Förderung

  • National Natural Science Foundation of China
  • Collaborative Innovation Center for Tumor Individualization Program
  • Doctoral Program for Entrepreneurship and Innovation of Jiangsu Province
  • Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University

Zitieren

APA

Wu, S., Liu, Y., Zeng, T., Zhou, T., Sun, Y., Deng, Y., Zhang, J., Li, G., & Yin, Y. (2025). Enhanced the Trans‐Cleavage Activity of CRISPR‐Cas12a Using Metal‐Organic Frameworks as Stimulants for Efficient Electrochemical Sensing of Circulating Tumor DNA. Advanced Science, 12(22). https://doi.org/10.1002/advs.202417206

Vancouver

Wu S, Liu Y, Zeng T, Zhou T, Sun Y, Deng Y, et al. Enhanced the Trans‐Cleavage Activity of CRISPR‐Cas12a Using Metal‐Organic Frameworks as Stimulants for Efficient Electrochemical Sensing of Circulating Tumor DNA. Advanced Science. 2025;12(22). doi:10.1002/advs.202417206

BibTeX
@article{Wu2025,
  author = {Wu, Shuai and Liu, Yincheng and Zeng, Tianyu and Zhou, Tianci and Sun, Yanting and Deng, Ying and Zhang, Juan and Li, Genxi and Yin, Yongmei},
  title = {Enhanced the Trans‐Cleavage Activity of CRISPR‐Cas12a Using Metal‐Organic Frameworks as Stimulants for Efficient Electrochemical Sensing of Circulating Tumor DNA},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {22},
  doi = {10.1002/advs.202417206}
}
Kostenlos starten →